THE SENATE S.R. NO. 145 THIRTY-FIRST LEGISLATURE, 2022 STATE OF HAWAII SENATE RESOLUTION Requesting the auditor to ASsess the social and financial effects of mandating health insurance coverage for oocyte cryopreservation.
THE SENATE S.R. NO. 145
THIRTY-FIRST LEGISLATURE, 2022
STATE OF HAWAII
THE SENATE
S.R. NO.
145
THIRTY-FIRST LEGISLATURE, 2022
STATE OF HAWAII
SENATE RESOLUTION
Requesting the auditor to ASsess the social and financial effects of mandating health insurance coverage for oocyte cryopreservation.
WHEREAS, women who undergo certain procedures such as chemotherapy and surgery, or who are at risk of premature ovarian failure or ovarian disease, have a high risk of infertility; and WHEREAS, health insurers are currently not required to cover procedures for oocyte cryopreservation, or egg freezing; and WHEREAS, S.B. No. 2917, S.D. 2, introduced during the Regular Session of 2022, requires health insurers, mutual benefit societies, and health maintenance organizations that provide coverage for health care to provide coverage for oocyte cryopreservation procedures; and WHEREAS, pursuant to section 23-51, Hawaii Revised Statutes, before any legislative measure that mandates health insurance coverage for specific health services, specific diseases, or certain providers of health care services as part of individual or group health insurance policies can be considered, there shall be concurrent resolutions passed that designates a specific legislative bill for the Auditor to review and on which to prepare a report for submission to the Legislature that assesses both the social and financial effects of the proposed mandated coverage, and S.B. No. 2917, S.D. 2 (2022), is such a measure; now, therefore, BE IT RESOLVED by the Senate of the Thirty-first Legislature of the State of Hawaii, Regular Session of 2022, that the Auditor is requested to conduct an assessment, pursuant to sections 23-51 and 23-52, Hawaii Revised Statutes, of the social and financial effects of mandating health insurance coverage for oocyte cryopreservation procedures, as proposed in S.B. No. 2917, S.D. 2, which was introduced during the Regular Session of 2022; and BE IT FURTHER RESOLVED that the Auditor is requested to submit a report of its findings and recommendations, including any proposed legislation, to the Legislature no later than twenty days prior to the convening of the Regular Session of 2023; and BE IT FURTHER RESOLVED that certified copies of this Resolution be transmitted to the Auditor and Insurance Commissioner. OFFERED BY: _____________________________ Report Title: Insurance; Oocyte Cryopreservation; Auditor
WHEREAS, women who undergo certain procedures such as chemotherapy and surgery, or who are at risk of premature ovarian failure or ovarian disease, have a high risk of infertility; and
WHEREAS, health insurers are currently not required to cover procedures for oocyte cryopreservation, or egg freezing; and
WHEREAS, S.B. No. 2917, S.D. 2, introduced during the Regular Session of 2022, requires health insurers, mutual benefit societies, and health maintenance organizations that provide coverage for health care to provide coverage for oocyte cryopreservation procedures; and
WHEREAS, pursuant to section 23-51, Hawaii Revised Statutes, before any legislative measure that mandates health insurance coverage for specific health services, specific diseases, or certain providers of health care services as part of individual or group health insurance policies can be considered, there shall be concurrent resolutions passed that designates a specific legislative bill for the Auditor to review and on which to prepare a report for submission to the Legislature that assesses both the social and financial effects of the proposed mandated coverage, and S.B. No. 2917, S.D. 2 (2022), is such a measure; now, therefore,
BE IT RESOLVED by the Senate of the Thirty-first Legislature of the State of Hawaii, Regular Session of 2022, that the Auditor is requested to conduct an assessment, pursuant to sections 23-51 and 23-52, Hawaii Revised Statutes, of the social and financial effects of mandating health insurance coverage for oocyte cryopreservation procedures, as proposed in S.B. No. 2917, S.D. 2, which was introduced during the Regular Session of 2022; and
BE IT FURTHER RESOLVED that the Auditor is requested to submit a report of its findings and recommendations, including any proposed legislation, to the Legislature no later than twenty days prior to the convening of the Regular Session of 2023; and
BE IT FURTHER RESOLVED that certified copies of this Resolution be transmitted to the Auditor and Insurance Commissioner.
OFFERED BY: _____________________________
OFFERED BY:
_____________________________
Report Title:
Insurance; Oocyte Cryopreservation; Auditor